These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 24804517)

  • 1. [MUC4 research progress in tumor molecular markers].
    Zhu H; You J
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2014 Feb; 31(1):233-6. PubMed ID: 24804517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muc4/MUC4 functions and regulation in cancer.
    Carraway KL; Theodoropoulos G; Kozloski GA; Carothers Carraway CA
    Future Oncol; 2009 Dec; 5(10):1631-40. PubMed ID: 20001800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant upregulation of MUC4 mucin expression in cutaneous condyloma acuminatum and squamous cell carcinoma suggests a potential role in the diagnosis and therapy of skin diseases.
    Chakraborty S; Swanson BJ; Bonthu N; Batra SK
    J Clin Pathol; 2010 Jul; 63(7):579-84. PubMed ID: 20591909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant methylation of MUC1 and MUC4 promoters are potential prognostic biomarkers for pancreatic ductal adenocarcinomas.
    Yokoyama S; Higashi M; Kitamoto S; Oeldorf M; Knippschild U; Kornmann M; Maemura K; Kurahara H; Wiest E; Hamada T; Kitazono I; Goto Y; Tasaki T; Hiraki T; Hatanaka K; Mataki Y; Taguchi H; Hashimoto S; Batra SK; Tanimoto A; Yonezawa S; Hollingsworth MA
    Oncotarget; 2016 Jul; 7(27):42553-42565. PubMed ID: 27283771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Role of Mucin Antigen MUC4 for Cholangiocarcinoma: A Meta-Analysis.
    Li B; Tang H; Zhang A; Dong J
    PLoS One; 2016; 11(6):e0157878. PubMed ID: 27305093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular-Associated Muc4/Vwf Co-Localization in Human Conjunctival Malignant Melanoma Specimens-Tumor Metastasis by Migration?
    Kakkassery V; Winterhalter S; Nick AC; Joachim SC; Joussen AM; Kociok N
    Curr Eye Res; 2017 Oct; 42(10):1382-1388. PubMed ID: 28622066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invasive micropapillary carcinoma of the breast overexpresses MUC4 and is associated with poor outcome to adjuvant trastuzumab in HER2-positive breast cancer.
    Mercogliano MF; Inurrigarro G; De Martino M; Venturutti L; Rivas MA; Cordo-Russo R; Proietti CJ; Fernández EA; Frahm I; Barchuk S; Allemand DH; Figurelli S; Deza EG; Ares S; Gercovich FG; Cortese E; Amasino M; Guzmán P; Roa JC; Elizalde PV; Schillaci R
    BMC Cancer; 2017 Dec; 17(1):895. PubMed ID: 29281999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathobiological implications of MUC4 in non-small-cell lung cancer.
    Majhi PD; Lakshmanan I; Ponnusamy MP; Jain M; Das S; Kaur S; Shimizu ST; West WW; Johansson SL; Smith LM; Yu F; Rolle CE; Sharma P; Carey GB; Batra SK; Ganti AK
    J Thorac Oncol; 2013 Apr; 8(4):398-407. PubMed ID: 23370366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MUC4 is a sensitive and extremely useful marker for sclerosing epithelioid fibrosarcoma: association with FUS gene rearrangement.
    Doyle LA; Wang WL; Dal Cin P; Lopez-Terrada D; Mertens F; Lazar AJ; Fletcher CD; Hornick JL
    Am J Surg Pathol; 2012 Oct; 36(10):1444-51. PubMed ID: 22982887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MUC4 expression is a novel prognostic factor in patients with invasive ductal carcinoma of the pancreas.
    Saitou M; Goto M; Horinouchi M; Tamada S; Nagata K; Hamada T; Osako M; Takao S; Batra SK; Aikou T; Imai K; Yonezawa S
    J Clin Pathol; 2005 Aug; 58(8):845-52. PubMed ID: 16049287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical expression profiles of mucin antigens in salivary gland mucoepidermoid carcinoma: MUC4- and MUC6-negative expression predicts a shortened survival in the early postoperative phase.
    Honjo K; Hiraki T; Higashi M; Noguchi H; Nomoto M; Yoshimura T; Batra SK; Yonezawa S; Semba I; Nakamura N; Tanimoto A; Yamada S
    Histol Histopathol; 2018 Feb; 33(2):201-213. PubMed ID: 28649694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The increase in the expression and hypomethylation of MUC4 gene with the progression of pancreatic ductal adenocarcinoma.
    Zhu Y; Zhang JJ; Zhu R; Zhu Y; Liang WB; Gao WT; Yu JB; Xu ZK; Miao Y
    Med Oncol; 2011 Dec; 28 Suppl 1():S175-84. PubMed ID: 20922503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DOG1 Expression in Low-Grade Fibromyxoid Sarcoma: A Study of 11 Cases, With Molecular Characterization.
    Thway K; Ng W; Benson C; Chapman J; Fisher C
    Int J Surg Pathol; 2015 Sep; 23(6):454-60. PubMed ID: 26135531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical impact of MUC1 and MUC4 expression in Barrett-associated oesophageal adenocarcinoma.
    Piessen G; Wacrenier A; Briez N; Triboulet JP; Van Seuningen I; Mariette C
    J Clin Pathol; 2009 Dec; 62(12):1144-6. PubMed ID: 19946103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MUC4 modulates human glioblastoma cell proliferation and invasion by upregulating EGFR expression.
    Li W; Wu C; Yao Y; Dong B; Wei Z; Lv X; Zhang J; Xu Y
    Neurosci Lett; 2014 Apr; 566():82-7. PubMed ID: 24582898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation and characterization of anti-MUC4 monoclonal antibodies reactive with normal and cancer cells in humans.
    Moniaux N; Varshney GC; Chauhan SC; Copin MC; Jain M; Wittel UA; Andrianifahanana M; Aubert JP; Batra SK
    J Histochem Cytochem; 2004 Feb; 52(2):253-61. PubMed ID: 14729877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MUC4 is a novel prognostic factor of intrahepatic cholangiocarcinoma-mass forming type.
    Shibahara H; Tamada S; Higashi M; Goto M; Batra SK; Hollingsworth MA; Imai K; Yonezawa S
    Hepatology; 2004 Jan; 39(1):220-9. PubMed ID: 14752841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NIDO, AMOP and vWD domains of MUC4 play synergic role in MUC4 mediated signaling.
    Zhu Y; Zhang JJ; Peng YP; Liu X; Xie KL; Tang J; Jiang KR; Gao WT; Tian L; Zhang K; Xu ZK; Miao Y
    Oncotarget; 2017 Feb; 8(6):10385-10399. PubMed ID: 28060749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MUC4: a novel prognostic factor of oral squamous cell carcinoma.
    Hamada T; Wakamatsu T; Miyahara M; Nagata S; Nomura M; Kamikawa Y; Yamada N; Batra SK; Yonezawa S; Sugihara K
    Int J Cancer; 2012 Apr; 130(8):1768-76. PubMed ID: 21618516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging roles of MUC4 in cancer: a novel target for diagnosis and therapy.
    Singh AP; Chaturvedi P; Batra SK
    Cancer Res; 2007 Jan; 67(2):433-6. PubMed ID: 17234748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.